ClinicalTrials.gov
public full text
Public Domain
Prospective, Non-randomized, Safety and Efficacy Study of a New Occluder Design for Minimally Invasive Closure of the Left Atrial Appendage (LAA) in Patients With Atrial Fibrillation
This is a prospective, non-randomized, study of the safety and efficacy of the Occlutech® LAA occluder indicated for percutaneous LAA closure in adult male or female patients with atrial fibrillation. Safety and efficacy will be assessed at day 1, 30 and 90, and after 1 year following implantation of an Occlutech® LAA Occluder.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Atrial Appendage Closure Prospective Observational Study#1071968
- Canadian Left Atrial Appendage Closure Study#892226
- Evaluation of the Safety and Efficacy of a Novel SeaLA™ Left Atrial Appendage Occluder#1031522
- Atrial Fibrillation TRIal of Left Atrial Appendage Closure Using Seralene Hemostatic Suture#1007591
- Post-approval Study of Percutaneous Left Atrial Appendage Closure ( FLAAC-2 )#903992
Record · ID 849543
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive